- Home
- BKTI vs AARD Comparison
BKTI vs AARD Comparison
Compare BKTI & AARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKTI
- AARD
- Stock Information
- Founded
- BKTI 1997
- AARD 2017
- Country
- BKTI United States
- AARD United States
- Employees
- BKTI N/A
- AARD N/A
- Industry
- BKTI Radio And Television Broadcasting And Communications Equipment
- AARD Biotechnology: Pharmaceutical Preparations
- Sector
- BKTI Technology
- AARD Health Care
- Exchange
- BKTI Nasdaq
- AARD Nasdaq
- Market Cap
- BKTI 156.7M
- AARD 154.9M
- IPO Year
- BKTI N/A
- AARD 2025
- Fundamental
- Price
- BKTI $42.54
- AARD $11.77
- Analyst Decision
- BKTI Strong Buy
- AARD Strong Buy
- Analyst Count
- BKTI 1
- AARD 4
- Target Price
- BKTI $55.00
- AARD $31.25
- AVG Volume (30 Days)
- BKTI 25.8K
- AARD 33.1K
- Earning Date
- BKTI 05-13-2025
- AARD 05-14-2025
- Dividend Yield
- BKTI N/A
- AARD N/A
- EPS Growth
- BKTI N/A
- AARD N/A
- EPS
- BKTI 2.59
- AARD N/A
- Revenue
- BKTI $77,415,000.00
- AARD N/A
- Revenue This Year
- BKTI $8.80
- AARD N/A
- Revenue Next Year
- BKTI $8.69
- AARD N/A
- P/E Ratio
- BKTI $16.76
- AARD N/A
- Revenue Growth
- BKTI 5.18
- AARD N/A
- 52 Week Low
- BKTI $11.67
- AARD $4.88
- 52 Week High
- BKTI $48.43
- AARD $19.58
- Technical
- Relative Strength Index (RSI)
- BKTI 46.66
- AARD N/A
- Support Level
- BKTI $42.85
- AARD N/A
- Resistance Level
- BKTI $46.40
- AARD N/A
- Average True Range (ATR)
- BKTI 2.31
- AARD 0.00
- MACD
- BKTI -0.28
- AARD 0.00
- Stochastic Oscillator
- BKTI 14.12
- AARD 0.00
About BKTI BK Technologies Corporation
BK Technologies Corp a holding company, operates through its subsidiary, BK Technologies, Inc., specializing in designing, manufacturing, and marketing wireless communications equipment. Its Radio business unit offers two-way land mobile radios (LMRs) serving government and public safety markets, as well as industrial and commercial enterprises. The SaaS business unit focuses on public safety smartphone applications, enhancing first responders' safety and efficiency. The BKRplay application, tethered to BK radios, amplifies user capabilities, expanding the reach of their radio sales. Its product portfolio consists of two-way land mobile radios, handheld radios, radios installed in vehicles.
About AARD Aardvark Therapeutics Inc. Common Stock
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.